For a fifth time this year, the FDA has scolded a pharma company for misleading marketing, this time over a Merz ...
Merz Therapeutics landed in hot water last month when the FDA said a social media promotion for its Botox rival Xeomin was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback